Literature DB >> 10555746

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar.

J C Taylor1, D R Ferry, C F Higgins, R Callaghan.   

Abstract

The gene encoding the multidrug resistance P-glycoprotein (P-gp) is duplicated in rodent species and the functional basis for this remains unresolved. Despite a high sequence similarity, the mouse P-gp1a and P-gp1b isoforms show distinct patterns of tissue distribution which suggest a specific role of the P-gp1b isoform in steroid transport. In the present study possible biochemical differences between the isoforms were directly investigated at the level of drug interaction. There was no detectable difference in the affinity or binding capacity of the two isoforms towards [3H]vinblastine at equilibrium. Similarly, the rate at which [3H]vinblastine associates with P-gp was indistinguishable between the two isoforms. Some modest differences were observed in the relative abilities of the multidrug-resistant (MDR) reversing agents CP100-356, nicardipine and verapamil to displace equilibrium [3H]vinblastine binding to P-gp1a and P-gp1b. The steroid hormone progesterone displayed a low affinity (Ki = 1.2 +/- 0.2 microM for P-gp1a and 3.5 +/- 0.5 microM for P-gp1b), suggesting an unlikely role as a physiological substrate. Thus the mouse isoforms do not appear to exhibit functional differences at the level of initial substrate interaction with protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555746      PMCID: PMC2374293          DOI: 10.1038/sj.bjc.6690764

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein.

Authors:  D R Gill; S C Hyde; C F Higgins; M A Valverde; G M Mintenig; F V Sepúlveda
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

2.  The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease.

Authors:  M A Valverde; T D Bond; S P Hardy; J C Taylor; C F Higgins; J Altamirano; F J Alvarez-Leefmans
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

3.  Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.

Authors:  S Orlowski; L M Mir; J Belehradek; M Garrigos
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

4.  Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.

Authors:  K M Barnes; B Dickstein; G B Cutler; T Fojo; S E Bates
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

5.  Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.

Authors:  M Garrigos; L M Mir; S Orlowski
Journal:  Eur J Biochem       Date:  1997-03-01

6.  P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.

Authors:  D R Ferry; M A Russell; M H Cullen
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

7.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

Authors:  K Ueda; N Okamura; M Hirai; Y Tanigawara; T Saeki; N Kioka; T Komano; R Hori
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

8.  Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

Authors:  S Ayesh; Y M Shao; W D Stein
Journal:  Biochim Biophys Acta       Date:  1996-05-24

9.  Differential transport properties of two mdr gene products are distinguished by progesterone.

Authors:  C P Yang; D Cohen; L M Greenberger; S I Hsu; S B Horwitz
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

10.  The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression.

Authors:  A E Trezise; P R Romano; D R Gill; S C Hyde; F V Sepúlveda; M Buchwald; C F Higgins
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  5 in total

1.  Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins.

Authors:  Guido J E J Hooiveld; Janette Heegsma; Jessica E van Montfoort; Peter L M Jansen; Dirk K F Meijer; Michael Müller
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 2.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.

Authors:  Mavis Jiarong Li; Abhinav Nath; William M Atkins
Journal:  Biochemistry       Date:  2017-05-04       Impact factor: 3.162

4.  Multidrug transporter activity in lymphocytes.

Authors:  James I Elliott; Selina Raguz; Christopher F Higgins
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

5.  In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.

Authors:  Salvatore Cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.